• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清型 B 群外膜囊泡展示 NadA、NHBA 和 fHbp 的特性和免疫原性

Characterisation and Immunogenicity of outer membrane vesicles displaying NadA, NHBA and fHbp from serogroup B.

机构信息

Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.

出版信息

Front Immunol. 2024 Sep 24;15:1473064. doi: 10.3389/fimmu.2024.1473064. eCollection 2024.

DOI:10.3389/fimmu.2024.1473064
PMID:39380985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11458423/
Abstract

More affordable and effective vaccines against bacterial meningitis caused by serogroup B are still required for global prevention. We have previously shown that modified outer membrane vesicles (mOMVs) from commensal can be used as a platform to induce immune responses against meningococcal antigens. The aim of the present study was to use a combination of two genetically engineered mOMVs to express multiple antigens from known to be involved in protective immunity to meningococcal meningitis (different variants of factor H binding protein (fHbp), Heparin Binding Antigen (NHBA) and Adhesin A (NadA)). Antigen expression in the mOMVs was confirmed by Western blotting; detoxification of the lipooligosaccharide (LOS) was confirmed by measuring human Toll-like receptor 4 (hTLR4) activation using cell assays. Mice immunised with a combination of two mOMVs expressing fHbp, NHBA and NadA produced antibodies to all the antigens. Furthermore, serum bactericidal activity (SBA) was induced by the immunisation, with mOMVs expressing NadA displaying high SBA titres against a MenB strain. The work highlights the potential of mOMVs from to induce functional immune responses against multiple antigens involved in the protective immune response to meningococcal disease.

摘要

仍然需要更经济实惠且有效的 B 群脑膜炎球菌疫苗来进行全球预防。我们之前已经表明,共生菌的修饰外膜囊泡(mOMVs)可用作诱导针对脑膜炎奈瑟菌抗原的免疫反应的平台。本研究的目的是使用两种基因工程化的 mOMVs 组合来表达已知参与对脑膜炎奈瑟菌脑膜炎的保护性免疫的多种抗原(来自 fHbp 的不同变体、肝素结合抗原(NHBA)和粘附素 A(NadA))。通过 Western blot 确认 mOMVs 中的抗原表达;通过使用细胞测定法测量人 Toll 样受体 4(hTLR4)的激活来确认脂寡糖(LOS)的解毒。用表达 fHbp、NHBA 和 NadA 的两种 mOMVs 组合免疫的小鼠产生针对所有抗原的抗体。此外,免疫接种诱导了血清杀菌活性(SBA),表达 NadA 的 mOMVs 对 MenB 菌株显示出高 SBA 效价。这项工作强调了来自 的 mOMVs 诱导针对参与脑膜炎奈瑟菌疾病保护性免疫的多种抗原的功能性免疫反应的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/34da9afcdad3/fimmu-15-1473064-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/b2771a68a02a/fimmu-15-1473064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/a272586a8527/fimmu-15-1473064-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/1184a7e79e89/fimmu-15-1473064-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/a0059bc994b0/fimmu-15-1473064-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/0fa8c306a278/fimmu-15-1473064-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/280e19c69f3a/fimmu-15-1473064-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/34da9afcdad3/fimmu-15-1473064-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/b2771a68a02a/fimmu-15-1473064-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/a272586a8527/fimmu-15-1473064-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/1184a7e79e89/fimmu-15-1473064-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/a0059bc994b0/fimmu-15-1473064-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/0fa8c306a278/fimmu-15-1473064-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/280e19c69f3a/fimmu-15-1473064-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba6f/11458423/34da9afcdad3/fimmu-15-1473064-g007.jpg

相似文献

1
Characterisation and Immunogenicity of outer membrane vesicles displaying NadA, NHBA and fHbp from serogroup B.血清型 B 群外膜囊泡展示 NadA、NHBA 和 fHbp 的特性和免疫原性
Front Immunol. 2024 Sep 24;15:1473064. doi: 10.3389/fimmu.2024.1473064. eCollection 2024.
2
Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.共生灰色奈瑟菌外膜囊泡作为将脑膜炎球菌和淋球菌抗原递送至免疫系统的平台。
Vaccine. 2023 Dec 18;41(52):7671-7681. doi: 10.1016/j.vaccine.2023.11.034. Epub 2023 Nov 25.
3
A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.一种脑膜炎球菌外膜囊泡疫苗,过表达突变 FHbp,在婴儿恒河猴中引起的保护性抗体反应高于已许可的 B 型脑膜炎球菌疫苗。
mBio. 2019 Jun 18;10(3):e01231-19. doi: 10.1128/mBio.01231-19.
4
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.多中心、开放性、随机、对照二期临床试验,研究在婴儿期接种含和不含外膜囊泡的新型重组 B 群脑膜炎球菌疫苗的效果。
Clin Infect Dis. 2010 Nov 15;51(10):1127-37. doi: 10.1086/656741. Epub 2010 Oct 18.
5
Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.美国大学校园两起B群脑膜炎球菌疫情中分离菌株对MenB-4C疫苗诱导的血清杀菌活性的敏感性
Clin Vaccine Immunol. 2015 Dec;22(12):1227-34. doi: 10.1128/CVI.00474-15. Epub 2015 Sep 30.
6
Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 isolates causing invasive meningococcal disease in Argentina in 2010-2014.2010-2014 年阿根廷 284 株侵袭性脑膜炎奈瑟菌分离株的遗传特征及 4CMenB 疫苗株的估计覆盖率。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2378537. doi: 10.1080/21645515.2024.2378537. Epub 2024 Jul 22.
7
A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccine.一种用于非洲的脑膜炎球菌NOMV-FHbp疫苗,与一种已获许可的B群疫苗相比,能引发针对B群和非B群菌株的更广泛的血清杀菌抗体反应。
Vaccine. 2016 Jan 27;34(5):643-649. doi: 10.1016/j.vaccine.2015.12.034. Epub 2015 Dec 20.
8
Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.淋病奈瑟菌同源物与 B 群脑膜炎奈瑟球菌外膜蛋白的遗传相似性。
mBio. 2019 Sep 10;10(5):e01668-19. doi: 10.1128/mBio.01668-19.
9
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.抗NHba抗体在B群脑膜炎球菌疫苗MenB-4C引发的杀菌活性中的作用。
Vaccine. 2017 Jul 24;35(33):4236-4244. doi: 10.1016/j.vaccine.2017.06.020. Epub 2017 Jun 23.
10
[Sequencing analysis of the antigens included in the four-component  vaccine against serogroup B meningococcus in Czech isolates of Neisseria meningitidis from 2007-2013].[2007 - 2013年捷克脑膜炎奈瑟菌分离株中B群脑膜炎球菌四价疫苗所含抗原的测序分析]
Epidemiol Mikrobiol Imunol. 2014 Feb;63(1):61-8.

引用本文的文献

1
Bioengineering Outer-Membrane Vesicles for Vaccine Development: Strategies, Advances, and Perspectives.用于疫苗开发的生物工程外膜囊泡:策略、进展与展望
Vaccines (Basel). 2025 Jul 20;13(7):767. doi: 10.3390/vaccines13070767.
2
Integrated proteomics reveals enrichment of oxidative stress and inflammatory proteins in the urine and stone matrix of calcium oxalate stone formers.综合蛋白质组学揭示了草酸钙结石形成者尿液和结石基质中氧化应激和炎症蛋白的富集。
Urolithiasis. 2025 Feb 6;53(1):25. doi: 10.1007/s00240-025-01697-1.

本文引用的文献

1
Commensal Neisseria cinerea outer membrane vesicles as a platform for the delivery of meningococcal and gonococcal antigens to the immune system.共生灰色奈瑟菌外膜囊泡作为将脑膜炎球菌和淋球菌抗原递送至免疫系统的平台。
Vaccine. 2023 Dec 18;41(52):7671-7681. doi: 10.1016/j.vaccine.2023.11.034. Epub 2023 Nov 25.
2
Evaluating Functional Immunity Following Encapsulated Bacterial Infection and Vaccination.评估包膜细菌感染和疫苗接种后的功能性免疫
Vaccines (Basel). 2021 Jun 20;9(6):677. doi: 10.3390/vaccines9060677.
3
Virulence genes and previously unexplored gene clusters in four commensal spp. isolated from the human throat expand the neisserial gene repertoire.
从人咽喉分离的 4 株共生 spp. 中的毒力基因和以前未探索的基因簇扩展了奈瑟氏菌的基因库。
Microb Genom. 2020 Sep;6(9). doi: 10.1099/mgen.0.000423. Epub 2020 Aug 26.
4
Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.脑膜炎球菌外膜囊泡疫苗中主要孔蛋白的缺失增强了对异源 B 群脑膜炎奈瑟菌菌株的反应性。
Vaccine. 2020 Feb 28;38(10):2396-2405. doi: 10.1016/j.vaccine.2020.01.038. Epub 2020 Feb 7.
5
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for vaccine.工程化的带有脂化抗原的细菌外膜囊泡作为疫苗平台。
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21780-21788. doi: 10.1073/pnas.1905112116. Epub 2019 Oct 7.
6
Meningococcal Serogroup A, B, C, W, X, and Y Serum Bactericidal Antibody Assays.A、B、C、W、X和Y群脑膜炎球菌血清杀菌抗体检测
Methods Mol Biol. 2019;1969:169-179. doi: 10.1007/978-1-4939-9202-7_12.
7
Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab.接种疫苗的依库珠单抗治疗患者中发生的无荚膜奈瑟脑膜炎奈瑟菌致死性疾病。
Emerg Infect Dis. 2018 Aug;24(8):1561-4. doi: 10.3201/eid2408.180228.
8
The Bexsero Neisseria meningitidis serogroup B vaccine antigen NHBA is a high-affinity chondroitin sulfate binding protein.Bexsero 脑膜炎奈瑟菌 B 群疫苗抗原 NHBA 是一种高亲和力的软骨素硫酸盐结合蛋白。
Sci Rep. 2018 Apr 25;8(1):6512. doi: 10.1038/s41598-018-24639-x.
9
MenB-FHbp Meningococcal Group B Vaccine (Trumenba): A Review in Active Immunization in Individuals Aged ≥ 10 Years.B 型脑膜炎球菌结合疫苗(特鲁姆巴)在 10 岁及以上人群中的主动免疫作用:一项综述。
Drugs. 2018 Feb;78(2):257-268. doi: 10.1007/s40265-018-0869-7.
10
The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.抗NHba抗体在B群脑膜炎球菌疫苗MenB-4C引发的杀菌活性中的作用。
Vaccine. 2017 Jul 24;35(33):4236-4244. doi: 10.1016/j.vaccine.2017.06.020. Epub 2017 Jun 23.